Home » Kilari Discusses Frontline Treatment Selection Factors for mRCC – Targeted Oncology

Kilari Discusses Frontline Treatment Selection Factors for mRCC – Targeted Oncology

by Targeted Oncology Staff | Jun 28, 2024 | Articles | 0 Comments